Metraipolis › archive › dc_e8ae39a3db37

PTEN homozygous deletion is a negative prognostic factor in tumor treating fields-treated glioblastoma, IDH wildtype patients — Europe PMC PMID:42722615

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42722615
DOI
10.1111/bpa.70143
License (as archived)
solo-consultazione
Archived
2026-10-15T19:59:04.109Z
SHA-256 of the archived text
02ef5ad131469a9840575c1813d7a97e730454ccd565f47bb25e0b51cc51c00e
Stable URL of this page
https://metraipolis.com/documento/dc_e8ae39a3db37

How to cite

PTEN homozygous deletion is a negative prognostic factor in tumor treating fields-treated glioblastoma, IDH wildtype patients — Europe PMC PMID:42722615 — Europe PMC (en), https://europepmc.org/article/MED/42722615 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e8ae39a3db37 (Metraipolis archive dc_e8ae39a3db37, sha256 02ef5ad131469a9840575c1813d7a97e730454ccd565f47bb25e0b51cc51c00e)
BibTeX
@misc{dce8ae39a3db37,
  title = {PTEN homozygous deletion is a negative prognostic factor in tumor treating fields-treated glioblastoma, IDH wildtype patients — Europe PMC PMID:42722615},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42722615},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e8ae39a3db37; sha256 02ef5ad131469a9840575c1813d7a97e730454ccd565f47bb25e0b51cc51c00e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42722615. Agents can read the archived copy with the MCP tool read_document.